Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP273796.RATgM36rX2HqHnAIQEhWLBOG05AF_V_5Nd_3nfPu9PZGs130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP273796.RATgM36rX2HqHnAIQEhWLBOG05AF_V_5Nd_3nfPu9PZGs130_assertion type Assertion NP273796.RATgM36rX2HqHnAIQEhWLBOG05AF_V_5Nd_3nfPu9PZGs130_head.
- NP273796.RATgM36rX2HqHnAIQEhWLBOG05AF_V_5Nd_3nfPu9PZGs130_assertion description "[The standard treatments for chronic lymphocytic leukemia (CLL) include the alkylating agent chlorambucil (CLB) and the nucleoside analog fludarabine (F-ara-AMP, Flu).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP273796.RATgM36rX2HqHnAIQEhWLBOG05AF_V_5Nd_3nfPu9PZGs130_provenance.
- NP273796.RATgM36rX2HqHnAIQEhWLBOG05AF_V_5Nd_3nfPu9PZGs130_assertion evidence source_evidence_literature NP273796.RATgM36rX2HqHnAIQEhWLBOG05AF_V_5Nd_3nfPu9PZGs130_provenance.
- NP273796.RATgM36rX2HqHnAIQEhWLBOG05AF_V_5Nd_3nfPu9PZGs130_assertion SIO_000772 14614459 NP273796.RATgM36rX2HqHnAIQEhWLBOG05AF_V_5Nd_3nfPu9PZGs130_provenance.
- NP273796.RATgM36rX2HqHnAIQEhWLBOG05AF_V_5Nd_3nfPu9PZGs130_assertion wasDerivedFrom befree-20140225 NP273796.RATgM36rX2HqHnAIQEhWLBOG05AF_V_5Nd_3nfPu9PZGs130_provenance.
- NP273796.RATgM36rX2HqHnAIQEhWLBOG05AF_V_5Nd_3nfPu9PZGs130_assertion wasGeneratedBy ECO_0000203 NP273796.RATgM36rX2HqHnAIQEhWLBOG05AF_V_5Nd_3nfPu9PZGs130_provenance.